p53 gene mutation in thyroid carcinoma

Cancer Letters

Volumn 103, Issue 1, 1996, Pages 57-63

  Ho, Yat Sen ^a   Tseng, Su Chu ^a   Chin, Ting Yu ^a   Hsieh, Ling Ling ^b   Lin, Jen Der ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

p53 gene; PCR SSCP; Thyroid carcinoma

Indexed keywords

PROTEIN P53; TUMOR MARKER;

ARTICLE; CELL NUCLEUS; CODON; CYTOPLASM; GENE MUTATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MISSENSE MUTATION; NUCLEIC ACID BASE SUBSTITUTION; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; STAINING; THYROID CARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 0029867407     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(96)04196-1     Document Type: Article

References (20)

1. Hedinger, C., Williamas, E.D. and Sobin, L.H. (1989) The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer, 63, 908-911.
2. Sakamoto, A., Kasai, N. and Sugano, H. (1983) Poorly differentiated carcinoma. A clinicopathologic entity for a high risk group of papillary and follicular carcinomas. Cancer, 52, 1849-1855.
3. Rosai, J., Carcangiu, ML. and DeLellis, R.A. (Editors) (1990) Tumors of the thyroid gland. In: Atlas of Tumor Pathology. Armed Forces Institute of Pathology, Washington, DC.
4. Carcangi, M.L., Zampi, G., Pupi, A. et al. (1985) Papillary carcinoma of the thyroid. A clinicopathological study of 241 cases treated at the University of Florence, Italy. Cancer, 55, 805-828.
5. Dubea, L., Chanddler, L.A., Gralow, J.R., Nicholas, P.W. and Jones, P.A. (1986) Southern blot analysis of DNA extracted from formalin-fixed pathology specimens. Cancer Res., 46, 2964-2969.
6. Porter, P.L., Gown, A.M., Kramp, S.G. and Coltrera, M.D. (1992) Widespread p53 overexpression in human malignant tumors. An immunohistochemical study using methacarn-fixed embedded tissue. Am. J. Pathol., 140, 145-153.
7. Suzuki, Y., Orita, M., Shiraisshi, M., Hayashi, K. and Sekiya, T. (1990) Detection of Ras gene mutations in human lung cancers by single strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene, 5, 1037-1043.
8. Fults, D., Tippets, R.H., Thomaass, G.A., Nakamura, Y. and White, R. (1989) Loss of heterozygosity for loci on chromosome 17p in human malignant astrocytoma. Cancer Res., 49, 6572-6577.
9. Jame, C.D., He, L., Carlbom, E., Mikkelsen, T., Ridderheim, P.A., Cavanee, W.K. and Collins, V.P. (1989) Loss of genetic information in central nervous system tumors common to children and young adults. Gene Chromosomes Cancer, 15, 579-581.
10. Shaulsky, G., Goldfinger, N., Peled, A. and Retter, V. (1991) Involvement of wild type p53 protein in the cell cycle requires nuclear localization. Cell Growth Differ., 2, 661-667.
11. Dobashi, Y., Sugimura, H., Sakamoto, A., Mernyei, M., Mori, M., Oyama, T. and Masshinami, R. (1994) Stepwise anticipation of p53 gene mutation during dedifferentiation of human thyroid carcinomas. Diagnostic Mol. Pathol., 3, 9-14.
12. Ito, T., Seyama, T., Mizuno, T., Tsuyama, N., Hayashi, Y., Dohi, K., Nakamura, N. and Akiyama, M. (1993) Genetic alterations in thyroid tumor progression: association with p53 gene mutations. Jpn. J. Cancer Res., 84, 526-531.
13. Dobashi, Y., Sakamoto, A., Sugimura, H., Mernyei, M., Mori, M., Oyama, T. and Mashinami, R. (1993) Overexpression of p53 as a possible prognostic factor in human thyroid carcinoma. Am. J. Surg. Pathol., 17, 375-381.
14. Fisher, C.J., Gilett, C.E., Vojtesek, B., Barnes, D.M. and Millis, R.R. (1994) Problems with p53 immunohistochemical staining: the effect of fixation and variation in the methods of evaluation. Br. J. Cancer, 69, 26-31.
15. Shaulsky, G., Goldfinger, N., Ben-Zeev, A. and Rotter, V. (1990) Nuclear accumulation of p53 protein is mediated by several nuclear localization signals and plays a role in tumorigenesis. Mol. Cell. Biol., 10, 6565-6577.
16. Wyllie, F.S., Haughton, M.F., Blaydes, J.P., Schlumberger, M. and Wynfor-Thomas, D. (1995) Evasion of p53-mediated growth control occurs by three alternative mechanisms in transformed thyroid epithelial cells. Oncogene, 10, 49-59.
17. McGrath, P.C., Sloan, D.A., Schwartz, R.W. and Kenady, D.E. (1994) Diagnosis and management of thyroid malignancies. Curr. Opin. Oncol., 6, 60-71.
18. Donghi, R. et al. (1993) Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland. J. Clin. Invest., 91, 1753-1760.
19. Wright, P.A., Lemoine, NR., Goretzki, P.A., Wyllie, F.S., Bond, J., Hughes, C., Roher, H.D., Williams, E.D. and Wynford-Thomas, D. (1993) Mutation of p53 gene in a differentiated human thyroid carcinoma cell line, but not in primary thyroid tumors. Oncogene, 6, 1693-1697.
20. Ito, T., Seyama, T., Mizuno, T., Tsuyama, N., Hayashi, T., Hayashi, Y., Dohi, K., Nakamura, N. and Akiyama, M. (1992) Unique association of p53 mutations with undifferentiated but not differentiated carcinoma of the thyroid gland. Cancer Res., 52, 1369-1371.